Stem cells gene edited to be HIV resistant treat ALL, but not HIVSeptember 11, 2019ALLLeukemia, Myelodysplasia, TransplantationTransplantation
Nonmyeloablative conditioning carries lowers infection risk in patients with AMLSeptember 10, 2019AMLTransplantationLeukemia, Myelodysplasia, Transplantation
Progressive myeloma after induction? Go straight to transplantSeptember 6, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersTransplantation
Novel conditioning regimen shows benefit for beta-thalassemia majorAugust 28, 2019Bleeding DisordersTransplantation
More abnormal cells linked to poorer ASCT outcomes in MDSMay 3, 2019TransplantationMyelodysplastic SyndromeLeukemia, Myelodysplasia, Transplantation
Biomarker testing may transform treatment of acute GVHDApril 26, 2019TransplantationLeukemia, Myelodysplasia, Transplantation
Monitoring, early intervention key to CAR T safetyApril 24, 2019Aggressive LymphomasTransplantationLymphoma & Plasma Cell Disorders
Quality of life decrement with salvage ASCT is short-livedApril 23, 2019Multiple MyelomaTransplantationLymphoma & Plasma Cell Disorders
ALF 2019 showcases evolving treatment of AMLApril 19, 2019AMLLeukemia, Myelodysplasia, TransplantationTransplantation
MRD status at transplant predicts outcomes in ALL patientsMarch 14, 2019TransplantationALLLeukemia, Myelodysplasia, Transplantation